Paul Tudor Jones’s SpringWorks Therapeutics SWTX Stock Holding History

Paul Tudor Jones’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-235,981	Closed	-$10.5M	–	3730
2025 Q1	$10.4M	Buy	+235,981	New	+$10.9M	0.03%	441
2024 Q1	–	Sell	-19,073	Closed	-$696K	–	2763
2023 Q4	$696K	Buy	+19,073	New	+$498K	0.01%	1620
2023 Q3	–	Sell	-21,197	Closed	-$556K	–	2850
2023 Q2	$556K	Buy	+21,197	New	+$557K	0.01%	1656
2022 Q3	–	Sell	-41,184	Closed	-$1.01M	–	2687
2022 Q2	$1.01M	Buy	41,184 +25,429	+161%	+$930K	0.03%	877
2022 Q1	$889K	Buy	+15,755	New	+$902K	0.02%	970
2021 Q2	–	Sell	-8,031	Closed	-$591K	–	1922
2021 Q1	$591K	Buy	+8,031	New	+$629K	0.01%	1075
2019 Q4	–	Sell	-10,276	Closed	-$223K	–	1375
2019 Q3	$223K	Buy	+10,276	New	+$243K	0.01%	935

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Paul Tudor Jones's SWTX Position: Q2 2025 in Review

Paul Tudor Jones sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 235,981 shares — an estimated $10.5M sold.

Paul Tudor Jones first reported a position in SWTX in Q3 2019 and held it in 7 quarters. The position peaked at $10.4M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Paul Tudor Jones reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Paul Tudor Jones sold 235,981 SpringWorks Therapeutics shares in Q2 2025, an estimated $10.5M.
Paul Tudor Jones first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 7 quarters.
Paul Tudor Jones's SpringWorks Therapeutics position peaked at $10.4M in Q1 2025.
223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.